Point72 Europe (London) LLP Maravai Lifesciences Holdings, Inc. Transaction History

Point72 Europe (London) LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $1.84 Million - $3.04 Million	268,122 Added 12.19%	2,468,465 $17.7 Million
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $2.07 Million - $3.54 Million	-404,144 Reduced 15.52%	2,200,343 $19.1 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $12.2 Million - $25.7 Million	2,604,487 New	2,604,487 $17.1 Million
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $774,000 - $1.15 Million	-30,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $735,000 - $925,800	30,000 New	30,000 $842,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $739M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

Stay updated on Point72 Europe (London) LLP with notifications on news.